HUP0301085A2 - Új peptid és alkalmazása szelektálási eljárásra - Google Patents

Új peptid és alkalmazása szelektálási eljárásra

Info

Publication number
HUP0301085A2
HUP0301085A2 HU0301085A HUP0301085A HUP0301085A2 HU P0301085 A2 HUP0301085 A2 HU P0301085A2 HU 0301085 A HU0301085 A HU 0301085A HU P0301085 A HUP0301085 A HU P0301085A HU P0301085 A2 HUP0301085 A2 HU P0301085A2
Authority
HU
Hungary
Prior art keywords
same
monoclonal antibody
screening method
human
novel peptide
Prior art date
Application number
HU0301085A
Other languages
English (en)
Inventor
Nobuaki Fujise
Masayoshi Kuriyama
Toshiko Satake
Ken Takahashi
Hideki Tanaka
Naohiro Washida
Original Assignee
Daiichi Pharmaceutical Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co. Ltd. filed Critical Daiichi Pharmaceutical Co. Ltd.
Publication of HUP0301085A2 publication Critical patent/HUP0301085A2/hu
Publication of HUP0301085A3 publication Critical patent/HUP0301085A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány tárgyát képezi egy új peptid, amely humán IgE elleni,humán típusú monoklonális antitesthez kötődik. A találmány tárgyátképezi továbbá a humán IgE elleni, humán típusú monoklonális antitesttalálmány szerinti peptid alkalmazásával végzett szelektálási(szkrínelési) eljárása; valamint a szkrínelési eljárással kapott,humán IgE elleni, humán típusú monoklonális antitest. A találmányszerinti eljárással kapott antitestek gyógyszerként hatásosanalkalmazhatók allergiás betegségek megelőzésére és/vagy kezelésére. Ó
HU0301085A 2000-01-14 2001-01-15 Novel peptide and screening method by using the same HUP0301085A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000007061 2000-01-14
PCT/JP2001/000181 WO2001051507A1 (fr) 2000-01-14 2001-01-15 Nouveau peptide et procede de criblage utilisant ledit peptide

Publications (2)

Publication Number Publication Date
HUP0301085A2 true HUP0301085A2 (hu) 2003-08-28
HUP0301085A3 HUP0301085A3 (en) 2005-06-28

Family

ID=18535491

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301085A HUP0301085A3 (en) 2000-01-14 2001-01-15 Novel peptide and screening method by using the same

Country Status (10)

Country Link
US (1) US20030092065A1 (hu)
EP (1) EP1249456A4 (hu)
KR (1) KR20020086893A (hu)
CN (1) CN1418222A (hu)
AU (1) AU778551B2 (hu)
CA (1) CA2396889A1 (hu)
HK (1) HK1048127A1 (hu)
HU (1) HUP0301085A3 (hu)
NO (1) NO20023364L (hu)
WO (1) WO2001051507A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009010765A (es) * 2007-04-02 2009-10-26 Amgen Fremont Inc Anticuerpos anti-ige.
JP7128191B2 (ja) 2017-01-06 2022-08-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 治療抗ＩｇＥ抗体並びにその方法及び組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63225397A (ja) * 1986-10-03 1988-09-20 Dainippon Pharmaceut Co Ltd 抗アレルギー作用を有する新規ペプチド
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Also Published As

Publication number Publication date
EP1249456A4 (en) 2004-09-08
HK1048127A1 (zh) 2003-03-21
HUP0301085A3 (en) 2005-06-28
US20030092065A1 (en) 2003-05-15
AU2552601A (en) 2001-07-24
CN1418222A (zh) 2003-05-14
NO20023364L (no) 2002-09-13
AU778551B2 (en) 2004-12-09
WO2001051507A1 (fr) 2001-07-19
NO20023364D0 (no) 2002-07-12
KR20020086893A (ko) 2002-11-20
EP1249456A1 (en) 2002-10-16
CA2396889A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
HUP0301235A2 (hu) Központi idegrendszeri betegségek kezelése glatiramer-acetát elleni antitestekkel
MXPA05003621A (es) Metodos de tratamiento de la enfermedad de alzheimer usando anticuerpos dirigidos contra el peptido beta amiloide y composiciones de los mismos.
TR200202253T2 (tr) IL-18 Kaynaklı rahatsızlıkların tedavisinde faydalı rekombinant IL-18 antagonistleri
HUP0402048A2 (hu) Eljárás specifikus patogének antigénjeinek azonosítására, izolálására és előállítására
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
RS51829B (sr) Ljudska antitela specifična za interleukin 15 (il-15)
UA111707C2 (uk) Застосування виділеного анти-tnf-альфа антитіла людини
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
HUP0303996A2 (hu) Vakcinakészítmények
NZ605429A (en) Therapeutic human anti-il-1r1 monoclonal antibody
AT500379B8 (de) Tau-proteine
IL165193A (en) Humanized immunomodulatory monoclonal antibodies and use thereof for the treatment of neoplastic disease
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
NZ568769A (en) Human monoclonal antibodies against CD20
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE222928T1 (de) Humanisierte antikörper gegen cd38
CA2469833A1 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
AU2003223285A1 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
TW200510528A (en) Polypeptide inducing apoptosis
EA200401081A1 (ru) Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro
DE69133242D1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
DE69127947D1 (de) Monoklonale Antikörper gegen menschliches IgE
DE60238987D1 (de) Behandlung von bauchspeicheldrüsenkrebs mit einem monoklonalen antikörper